• Citer

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.

par Vereecken, Pierre ;Awada, Ahmad ;Suciu, Stefan ;Castro, Gilberto;Morandini, R;Litynska, Anna;Lienard, D;Ezzedine, Khaled K ;Ghanem, Ghanem Elias ;Heenen, Michel
Référence Melanoma research, 19, 5, page (316-320)
Publication Publié, 2009-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.
Auteur:	Vereecken, Pierre; Awada, Ahmad; Suciu, Stefan; Castro, Gilberto; Morandini, R; Litynska, Anna; Lienard, D; Ezzedine, Khaled K; Ghanem, Ghanem Elias; Heenen, Michel
Informations sur la publication:	Melanoma research, 19, 5, page (316-320)
Statut de publication:	Publié, 2009-10
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Biomarkers
	C-reactive protein
	Galectin-3
	Lactate dehydrogenase
	Melanoma
	Prognosis
	S100B
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	C-Reactive Protein -- metabolism
	Female
	Galectin 3 -- blood
	Humans
	Kaplan-Meiers Estimate
	Male
	Melanoma -- blood
	Melanoma -- pathology
	Melanoma -- secondary
	Middle Aged
	Multivariate Analysis
	Neoplasm Staging
	Prognosis
	S100 Proteins -- blood
	Survival Analysis
	Tumor Markers, Biological -- blood
	Young Adult
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0960-8931
	info:doi/10.1097/CMR.0b013e32832ec001
	info:scp/73349088135
	info:pmid/19581819